OneMedNet Corp has announced a strategic multi-year partnership with Palantir Technologies Inc. This collaboration is set to significantly advance OneMedNet's capabilities in healthcare artificial intelligence and real-world data analytics. The company aims to tap into the rapidly growing AI healthcare market, projected to reach $868 billion by 2030, by utilizing secure and scalable data-driven solutions.
The core of this partnership involves integrating Palantir's Artificial Intelligence Platform, renowned for its ability to manage intricate datasets and provide timely insights, with OneMedNet's extensive network. This network boasts access to over 5 billion administrative claims and 131 million clinical examinations from more than 1,750 healthcare providers. The alliance will focus on critical therapeutic areas, including oncology, cardiology, and rare diseases, ultimately powering OneMedNet's iRWD near real-time AI-enabled provider network.
Through Palantir's platform, OneMedNet will offer life sciences, medical device, and research organizations access to anonymized, regulatory-grade clinical data and sophisticated analytics. This access is expected to accelerate the development of groundbreaking medical innovations. Aaron Green, President and CEO of OneMedNet, emphasized that Palantir's AIP will transform their ability to deliver high-quality, regulatory-compliant data with remarkable speed, fostering advancements in clinical research and AI-driven healthcare solutions.
This collaboration between OneMedNet and Palantir marks a pivotal moment in healthcare technology, promising to unlock new frontiers in medical research and patient care. By combining robust data analytics with cutting-edge AI, the partnership is poised to drive forward the development of more effective and personalized healthcare solutions, ultimately benefiting countless lives and shaping the future of medicine.